An innovative therapy combining CAR T-cells and CRISPR gene editing shows promise in sending autoimmune diseases into remission, offering new hope for patients with severe conditions.
The End of Temporary Protection: U.S. Decision Threatens the Future of Migrants
A mother and her two children sitting on the floor